Role of MIP-2 in coxsackievirus B3 myocarditis

被引:26
作者
Kishimoto, C
Kawamata, H
Sakai, S
Shinohara, H
Ochiai, H
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 2, Fac Med, Toyama 9300152, Japan
[2] Toyama Med & Pharmaceut Univ, Dept Oriental Med, Fac Med, Toyama 9300152, Japan
[3] Toyama Med & Pharmaceut Univ, Dept Human Sci, Fac Med, Toyama 9300152, Japan
关键词
myocarditis; coxsackievirus B3; macrophage inflammatory protein-2; interleukin; 8; T cells;
D O I
10.1006/jmcc.2000.1102
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Interleukin-8 (IL-8) is a chemotactic cytokine for neutrophils and lymphocytes. Macrophage inflammatory protein-2 (MIP-2) is a murine counterpart of IL-8. The present study was performed to determine the role of MIP-2, in murine myocarditis. We examined (1) the MIP-2 producing activity of Coxsackievirus B3 (CB3)-infected cultured macrophages, (2) serial plasma MIP-2 levels in CBS-induced mice by enzyme-linked immunosorbent assay (ELISA), and (3) the effects of anti-mouse MIP-2 monoclonal antibody (mAb) in vivo upon myocarditis. The production of MIP-2 increased in an infection dose- and time-dependent manner in virus-infected RAW 264.7 macrophages. Three-week-old C3H/He mice were inoculated with CB3, Plasma MIP-2 levels were significantly elevated in mice on days 7, 10 and 14 post-infection, Mice were injected subcutaneously with anti-MIP-2 mAb at 10 mu g/day (Group 2) or 100 mu g/day (Group 3) on days 0-7, and were observed until day 14. Uninfected control mice (Group 1) were injected with saline. Survival rate was higher in the anti-MIP-2-treated group (Group 3), but not in Group 2, than in the control group, Histopathological analysis revealed that cellular infiltration and myocardial necrosis with macrophage and T cell accumulation were less prominent in the anti-MIP-2 mAb-treated groups as compared to the controls. MIP-2 is an important naturally occurring inflammatory cytokine in CB3 myocarditis, and anti-MIP-2 mAb treatment may prevent the inflammatory response. (C) 2000 Academic Press.
引用
收藏
页码:631 / 638
页数:8
相关论文
共 26 条
[1]
DETECTION OF INTERLEUKIN-8 BIOLOGICAL-ACTIVITY IN SYNOVIAL-FLUIDS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND PRODUCTION OF INTERLEUKIN-8 MESSENGER-RNA BY ISOLATED SYNOVIAL-CELLS [J].
BRENNAN, FM ;
ZACHARIAE, COC ;
CHANTRY, D ;
LARSEN, CG ;
TURNER, M ;
MAINI, RN ;
MATSUSHIMA, K ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) :2141-2144
[2]
REQUIREMENT OF MIP-1-ALPHA FOR AN INFLAMMATORY RESPONSE TO VIRAL-INFECTION [J].
COOK, DN ;
BECK, MA ;
COFFMAN, TM ;
KIRBY, SL ;
SHERIDAN, JF ;
PRAGNELL, IB ;
SMITHIES, O .
SCIENCE, 1995, 269 (5230) :1583-1585
[3]
ACTIVE MYOCARDITIS IN THE SPECTRUM OF ACUTE DILATED CARDIOMYOPATHIES - CLINICAL-FEATURES, HISTOLOGIC CORRELATES, AND CLINICAL OUTCOME [J].
DEC, GW ;
PALACIOS, IF ;
FALLON, JT ;
ARETZ, HT ;
MILLS, J ;
LEE, DCS ;
JOHNSON, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (14) :885-890
[4]
MIP-1α as a critical macrophage chemoattractant in murine wound repair [J].
DiPietro, LA ;
Burdick, M ;
Low, QE ;
Kunkel, SL ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1693-1698
[5]
MODULATION OF NEUTROPHIL INFLUX IN GLOMERULONEPHRITIS IN THE RAT WITH ANTIMACROPHAGE INFLAMMATORY PROTEIN-2 (MIP-2) ANTIBODY [J].
FENG, LL ;
XIA, YY ;
YOSHIMURA, T ;
WILSON, CB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1009-1017
[6]
DIAGNOSIS AND CLASSIFICATION OF MYOCARDITIS BY ENDOMYOCARDIAL BIOPSY [J].
FENOGLIO, JJ ;
URSELL, PC ;
KELLOGG, CF ;
DRUSIN, RE ;
WEISS, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (01) :12-18
[7]
EFFECTS OF POLYETHYLENE-GLYCOL CONJUGATED SUPEROXIDE-DISMUTASE ON COXSACKIEVIRUS B3 MYOCARDITIS IN MICE [J].
HIRAOKA, Y ;
KISHIMOTO, C ;
KUROKAWA, M ;
OCHIAI, H ;
SASAYAMA, S .
CARDIOVASCULAR RESEARCH, 1992, 26 (10) :956-961
[8]
ROLE OF OXYGEN-DERIVED FREE-RADICALS IN THE PATHOGENESIS OF COXSACKIEVIRUS-B3 MYOCARDITIS IN MICE [J].
HIRAOKA, Y ;
KISHIMOTO, C ;
TAKADA, H ;
KUROKAWA, M ;
OCHIAI, H ;
SHIRAKI, K ;
SASAYAMA, S .
CARDIOVASCULAR RESEARCH, 1993, 27 (06) :957-961
[9]
Modification of viral myocarditis in mice by interleukin-6 [J].
Kanda, T ;
McManus, JEW ;
Nagai, R ;
Imai, S ;
Suzuki, T ;
Yang, DC ;
McManus, BM ;
Kobayashi, I .
CIRCULATION RESEARCH, 1996, 78 (05) :848-856
[10]
CYTOKINE AND MURINE COXSACKIEVIRUS B3 MYOCARDITIS - INTERLEUKIN-2 SUPPRESSED MYOCARDITIS IN THE ACUTE STAGE BUT ENHANCED THE CONDITION IN THE SUBSEQUENT STAGE [J].
KISHIMOTO, C ;
KUROKI, Y ;
HIRAOKA, Y ;
OCHIAI, H ;
KUROKAWA, M ;
SASAYAMA, S .
CIRCULATION, 1994, 89 (06) :2836-2842